Proteins and Peptides

21 Feb 2007 Bentley Announces Approval and Expansion of Its Nasulin Phase II Studies in India
21 Feb 2007 Dyax and Genzyme Announce Agreement to Terminate Joint Venture for the Commercialization of DX-88 in HAE
17 Feb 2007 OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
16 Feb 2007 Stem Cell Sciences and Celogos Sign a Licensing Deal on Autogenous Myoblast Transplantation For Urinary Incontinence Therapy
16 Feb 2007 FDA Accepts ZymoGenetics' Recombinant Human Thrombin Application for Review
15 Feb 2007 Halozyme and Baxter Expand Global HYLENEX Collaboration
15 Feb 2007 Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study
14 Feb 2007 Sangart, Inc. Initiates Phase III Clinical Trials
13 Feb 2007 Ambrx Initiates Phase I/II Clinical Trial of Novel Human Growth Hormone Product Candidate
13 Feb 2007 QSV Biologics, Ltd., and Critical Biologics Corp., Sign Contract for cGMP Manufacture of Gelsolin for Critical Care Applications
09 Feb 2007 Zelos Therapeutics' Ostabolin-CTM Increases Bone Mineral Density in Phase 2 Osteoporosis Trial
09 Feb 2007 EU-Approval for Continuous Infusion of KOGENATE(R) Bayer
09 Feb 2007 LAB International Completes Patient Enrollment in Its Growth Hormone Releasing Hormone (GHRH) Product Phase IIA Trial
09 Feb 2007 Amarillo Biosciences Announces Open Enrollment in Its Phase 2 Study of Orally Administered Interferon Alpha in the Treatment of Oral Warts in HIV-Positive Patients
09 Feb 2007 Presentations at Stroke Conference Update Development of Viprinex(TM) (ancrod)
07 Feb 2007 Jerini expands collaboration with Baxter to develop non-intraveneous hemophilia therapy
07 Feb 2007 Gloucester Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial in Patients with Multiple Myeloma
06 Feb 2007 Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
06 Feb 2007 Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
03 Feb 2007 Adnexus Therapeutics Announces Presentation Of Interim Phase I Results For CT-322, First Adnectin Therapeutic In Humans
02 Feb 2007 Overview On 2006 Sales Of TOP 20 Biologics To Be Released On February 26
02 Feb 2007 Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline
02 Feb 2007 Grifols announces FDA approval of Alphanate(R) to treat von Willebrand disease
02 Feb 2007 Successful Oral Insulin Toxicity Result - Oradel(TM), Loaded With Generic Insulin
31 Jan 2007 Gloucester Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase II Trial of Romidepsin in Patients with Peripheral T-Cell Lymphoma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up